[人Site] DEEPNOID CEO, Woo-Sik Choi "Differentiation in Medical AI with Customized Solution”

August 27, 2018

 

Differentiation in Clinical Research and EducationLike other medical AI companies, DEEPNOID is also having its business direction in the area of supportive diagnostic AI; supporting diseases are cerebral aneurysms, dental cysts, lung diseases, and spinal compression fractures. In addition, the differentiating factor of DEEPNOID is that it can be utilized as a training tool in the medical school and as the clinical trial support in the hospitals. Based on this business model, the ultimate goal is to open an independent diagnostic paradigm of AI.

 

 

http://www.etnews.com/20180827000228

 

Share on Facebook
Share on Twitter
Please reload

Featured Posts

"근골격계질환 의료AI로 2021년 미국 시장 진출하겠다"

June 10, 2019

1/9
Please reload

Recent Posts
Please reload

+82-2-6952-6001

©2019 DEEPNOID Inc.